Venture Life Group plc
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a VLG.L research report →
Companywww.venture-life.com
Venture Life Group plc develops and commercializes oral care products, food supplements, medical devices, dermo-cosmetics, and topical products for the ageing population in the United Kingdom, the Netherlands, China, Germany, Italy, Switzerland, rest of Europe, and internationally. It operates through Venture Life Brands and Customer Brands segments. The company offers neurology products, including NeuroAge, NeuroAge Sleep, and NeuroAge NRG food supplements to enhance alertness, cognitive function, and mental performance in healthy brain; and Original Bioscalin to treat and prevent hair loss, hair thinning, and baldness.
- CEO
- Jeremy Anthony Philip Randall
- IPO
- 2014
- Employees
- 165
- HQ
- Bracknell, GB
Price Chart
Valuation
- Market Cap
- $68.69M
- P/E
- 11.86
- P/S
- 1.95
- P/B
- 0.89
- EV/EBITDA
- 7.14
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 39.27%
- Op Margin
- 2.97%
- Net Margin
- 17.42%
- ROE
- 7.82%
- ROIC
- 1.18%
Growth & Income
- Revenue
- $35.17M · 32.24%
- Net Income
- $6.13M · 2050.64%
- EPS
- $0.05 · 2016.00%
- Op Income
- $1.05M
- FCF YoY
- -103.70%
Performance & Tape
- 52W High
- $72.00
- 52W Low
- $48.00
- 50D MA
- $62.83
- 200D MA
- $61.86
- Beta
- 0.24
- Avg Volume
- 204.90K
Get TickerSpark's AI analysis on VLG.L
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our VLG.L Coverage
We haven't published any research on VLG.L yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate VLG.L Report →